SOURCE: Equities Awareness Group

Equities Awareness Group

May 14, 2013 07:30 ET

PremierEquityReports.com Adds Cellceutix Corp. (OTCQB: CTIX) to Watch List; Provides Update on Nuvilex Inc. (OTCQB: NVLX), Lot78 Inc. (OTCQB: LOTE), and Multi-Corp International Inc. (PINKSHEETS: MULI)

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Equities Awareness Group LLC

NEW YORK, NY--(Marketwired - May 14, 2013) - PremierEquityReports.com, the U.S. leader in equity reports, offers quality reports to investors looking for the most undervalued companies in the market. Premier Equity Reports provides its subscribers with timely information and exclusive analysis on U.S. companies with substantial upside potential and today issues a report on Cellceutix Corp. (OTCQB: CTIX) and provides an update on recent picks Nuvilex Inc. (OTCQB: NVLX), Lot78 Inc. (OTCQB: LOTE), and Multi-Corp International Inc. (PINKSHEETS: MULI)

Click here -- www.PremierEquityReports.com

Today, Premier Equity Reports adds Cellceutix Corp. (OTCQB: CTIX) to their Watch List and provides an update on the following companies:

  • Nuvilex Inc. (OTCQB: NVLX) first alerted on March 21st at $0.053
  • Lot78 Inc. (OTCQB: LOTE) first alerted on March 19th at $1.02.
  • Multi-Corp International Inc. (PINKSHEETS: MULI) alerted on May 9th at $0.50.

Cellceutix Corp. (OTCQB: CTIX) Technical Alert. Cellceutix Corp. (OTCQB: CTIX) has gained about 42% on nearly 10 times the average 3 month trading volume. This massive increase in trading a surge in price per share has come in absence of any ground-breaking press releases issued by the company. Keep an eye on Cellceutix Corp.

Nuvilex Inc. (OTCQB: NVLX) Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status. Nuvilex (OTCQB: NVLX) is preparing for a large scale Phase III trial to treat advanced, inoperable pancreatic cancer using its cell encapsulation technology combined with a cancer killing drug. Dr. Gerald Crabtree is no stranger to late-stage clinical trials and had a role with the Bristol-Myers Squibb team that developed the blockbuster cancer drug, Taxol.

Nuvilex (OTCQB: NVLX) has gained approximately 315% from our initial alert on March 21st at $0.053.

Lot78 Inc. (OTCQB: LOTE) has absolutely exploded recently hitting a high of $12.32. We initiated coverage on this company initially on March 19th at $1.02 making for an astonishing 1,108% gain.

Although Lot78 (OTCQB: LOTE) may still continue higher over the next couple days, a prudent trader/investor should be taking profits. Please note that no member of our team is a licensed financial advisor and cannot give sell recommendations.

Multi-Corp International Inc. (PINKSHEETS: MULI) Announces New Drilling program Targeting Cave pool Property in Eddy County, NM with $79,433,000 Net Present Value. Multi-Corp (PINKSHEETS: MULI) has engaged MCI Operating of NM LLC to license and operate a summer drilling program for the first of two drill targets on leases owned in the Cave Pool property that covers 2,800 acres. According to a release issued by the Company, an independent reserve evaluation report completed in Q1, 2013 showed a net present value of $79,433,000 in P1 and P2 reserves.

Multi-Corp (PINKSHEETS: MULI) has gained approximately 178% from our initial alert on May 9th.

Premier Equity Reports also offers a FREE text message alert service to ensure that you receive all alerts. Using your mobile phone, simply text "reports" to 63566.

Keep a close eye on these companies and sign up to www.PremierEquityReports.com to receive full, comprehensive reports.

Sign Up Now and find out why thousands have joined already!

Disclosure: PremierEquityReports.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Premier Equity Reports is a wholly owned entity of Equities Awareness Group LLC. Equities Awareness Group LLC has not been compensated by any of the companies mentioned above. Please read our report and visit our website, for complete risks and disclosures.